Imaging of Liver Tumors Using Surface-Enhanced Raman Scattering Nanoparticles

Complete surgical resection is the ideal first-line treatment for most liver malignancies. This goal would be facilitated by an intraoperative imaging method that enables more precise visualization of tumor margins and detection of otherwise invisible microscopic lesions. To this end, we synthesized...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:ACS nano Ročník 10; číslo 5; s. 5015 - 5026
Hlavní autoři: Andreou, Chrysafis, Neuschmelting, Volker, Tschaharganeh, Darjus-Felix, Huang, Chun-Hao, Oseledchyk, Anton, Iacono, Pasquale, Karabeber, Hazem, Colen, Rivka R, Mannelli, Lorenzo, Lowe, Scott W, Kircher, Moritz F
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States American Chemical Society 24.05.2016
Témata:
ISSN:1936-0851, 1936-086X, 1936-086X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Complete surgical resection is the ideal first-line treatment for most liver malignancies. This goal would be facilitated by an intraoperative imaging method that enables more precise visualization of tumor margins and detection of otherwise invisible microscopic lesions. To this end, we synthesized silica-encapsulated surface-enhanced Raman scattering (SERS) nanoparticles (NPs) that act as a molecular imaging agent for liver malignancies. We hypothesized that, after intravenous administration, SERS NPs would avidly home to healthy liver tissue but not to intrahepatic malignancies. We tested these SERS NPs in genetically engineered mouse models of hepatocellular carcinoma and histiocytic sarcoma. After intravenous injection, liver tumors in both models were readily identifiable with Raman imaging. In addition, Raman imaging using SERS NPs enabled detection of microscopic lesions in liver and spleen. We compared the performance of SERS NPs to fluorescence imaging using indocyanine green (ICG). We found that SERS NPs delineate tumors more accurately and are less susceptible to photobleaching. Given the known advantages of SERS imaging, namely, high sensitivity and specific spectroscopic detection, these findings hold promise for improved resection of liver cancer.
AbstractList Complete surgical resection is the ideal first-line treatment for most liver malignancies. This goal would be facilitated by an intraoperative imaging method that enables more precise visualization of tumor margins and detection of otherwise invisible microscopic lesions. To this end, we synthesized silica-encapsulated surface-enhanced Raman scattering (SERS) nanoparticles (NPs) that act as a molecular imaging agent for liver malignancies. We hypothesized that, after intravenous administration, SERS NPs would avidly home to healthy liver tissue but not to intrahepatic malignancies. We tested these SERS NPs in genetically engineered mouse models of hepatocellular carcinoma and histiocytic sarcoma. After intravenous injection, liver tumors in both models were readily identifiable with Raman imaging. In addition, Raman imaging using SERS NPs enabled detection of microscopic lesions in liver and spleen. We compared the performance of SERS NPs to fluorescence imaging using indocyanine green (ICG). We found that SERS NPs delineate tumors more accurately and are less susceptible to photobleaching. Given the known advantages of SERS imaging, namely, high sensitivity and specific spectroscopic detection, these findings hold promise for improved resection of liver cancer.
Complete surgical resection is the ideal first-line treatment for most liver malignancies. This goal would be facilitated by an intraoperative imaging method that enables more precise visualization of tumor margins and detection of otherwise invisible microscopic lesions. To this end, we synthesized silica-encapsulated surface-enhanced Raman scattering (SERS) nanoparticles (NPs) that act as a molecular imaging agent for liver malignancies. We hypothesized that, after intravenous administration, SERS NPs would avidly home to healthy liver tissue but not to intrahepatic malignancies. We tested these SERS NPs in genetically engineered mouse models of hepatocellular carcinoma and histiocytic sarcoma. After intravenous injection, liver tumors in both models were readily identifiable with Raman imaging. In addition, Raman imaging using SERS NPs enabled detection of microscopic lesions in liver and spleen. We compared the performance of SERS NPs to fluorescence imaging using indocyanine green (ICG). We found that SERS NPs delineate tumors more accurately and are less susceptible to photobleaching. Given the known advantages of SERS imaging, namely, high sensitivity and specific spectroscopic detection, these findings hold promise for improved resection of liver cancer.Complete surgical resection is the ideal first-line treatment for most liver malignancies. This goal would be facilitated by an intraoperative imaging method that enables more precise visualization of tumor margins and detection of otherwise invisible microscopic lesions. To this end, we synthesized silica-encapsulated surface-enhanced Raman scattering (SERS) nanoparticles (NPs) that act as a molecular imaging agent for liver malignancies. We hypothesized that, after intravenous administration, SERS NPs would avidly home to healthy liver tissue but not to intrahepatic malignancies. We tested these SERS NPs in genetically engineered mouse models of hepatocellular carcinoma and histiocytic sarcoma. After intravenous injection, liver tumors in both models were readily identifiable with Raman imaging. In addition, Raman imaging using SERS NPs enabled detection of microscopic lesions in liver and spleen. We compared the performance of SERS NPs to fluorescence imaging using indocyanine green (ICG). We found that SERS NPs delineate tumors more accurately and are less susceptible to photobleaching. Given the known advantages of SERS imaging, namely, high sensitivity and specific spectroscopic detection, these findings hold promise for improved resection of liver cancer.
Complete surgical resection is the first-line treatment for most liver malignancies. This goal would be facilitated by an intraoperative imaging method that enables more precise visualization of tumor margins, and detection of otherwise invisible microscopic lesions. To this end, we synthesized silica-encapsulated surface-enhanced Raman scattering (SERS) nanoparticles (NPs) that act as a molecular imaging agent for liver malignancies. We hypothesized that, after intravenous administration, SERS NPs would avidly home to healthy liver tissue, but not to intrahepatic malignancies. We tested these SERS NPs in genetically engineered mouse models of hepatocellular carcinoma and histiocytic sarcoma. After intravenous injection, liver tumors in both models were readily identifiable with Raman imaging. In addition, Raman imaging using SERS NPs enabled detection of microscopic lesions in liver and spleen. We compared the performance of SERS NPs to fluorescence imaging using Indocyanine Green (ICG). We found that SERS NPs delineate tumors more accurately and are less susceptible to photobleaching. Given the known advantages of SERS imaging, namely high sensitivity and specific spectroscopic detection, these findings hold promise for improved resection of liver cancer.
Author Mannelli, Lorenzo
Neuschmelting, Volker
Colen, Rivka R
Kircher, Moritz F
Lowe, Scott W
Karabeber, Hazem
Huang, Chun-Hao
Andreou, Chrysafis
Tschaharganeh, Darjus-Felix
Oseledchyk, Anton
Iacono, Pasquale
AuthorAffiliation Department of Radiology, M.D. Anderson Cancer Center
Howard Hughes Medical Institute
Cancer Biology and Genetics Program
University of Texas
Center for Molecular Imaging and Nanotechnology (CMINT)
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College
Department of Radiology
AuthorAffiliation_xml – name: Department of Radiology
– name: Weill Cornell Medical College
– name: Department of Radiology, M.D. Anderson Cancer Center
– name: University of Texas
– name: Memorial Sloan Kettering Cancer Center
– name: Center for Molecular Imaging and Nanotechnology (CMINT)
– name: Howard Hughes Medical Institute
– name: Cancer Biology and Genetics Program
– name: 1 Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
– name: 2 Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
– name: 6 Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA
– name: 5 Center for Molecular Imaging and Nanotechnology (CMINT), Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
– name: 4 Howard Hughes Medical Institute, New York, NY 10065, USA
– name: 3 Department of Radiology, M.D. Anderson Cancer Center, University of Texas, Houston, Texas, 77030, USA
Author_xml – sequence: 1
  givenname: Chrysafis
  surname: Andreou
  fullname: Andreou, Chrysafis
– sequence: 2
  givenname: Volker
  surname: Neuschmelting
  fullname: Neuschmelting, Volker
– sequence: 3
  givenname: Darjus-Felix
  surname: Tschaharganeh
  fullname: Tschaharganeh, Darjus-Felix
– sequence: 4
  givenname: Chun-Hao
  surname: Huang
  fullname: Huang, Chun-Hao
– sequence: 5
  givenname: Anton
  surname: Oseledchyk
  fullname: Oseledchyk, Anton
– sequence: 6
  givenname: Pasquale
  surname: Iacono
  fullname: Iacono, Pasquale
– sequence: 7
  givenname: Hazem
  surname: Karabeber
  fullname: Karabeber, Hazem
– sequence: 8
  givenname: Rivka R
  surname: Colen
  fullname: Colen, Rivka R
– sequence: 9
  givenname: Lorenzo
  surname: Mannelli
  fullname: Mannelli, Lorenzo
– sequence: 10
  givenname: Scott W
  surname: Lowe
  fullname: Lowe, Scott W
– sequence: 11
  givenname: Moritz F
  surname: Kircher
  fullname: Kircher, Moritz F
  email: kircherm@mskcc.org
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27078225$$D View this record in MEDLINE/PubMed
BookMark eNp9kd1r2zAUxcXIWNtsz3sbfhwUN5JtSdbLoJR-QdbC2sDexI18larYUibZhf73dUgaukH3JKH7O-eIe47IxAePhHxl9ITRgs3AJA8-nPAllQWlH8ghU6XIaS1-T_Z3zg7IUUqPlHJZS_GJHBSSyroo-CH5ed3ByvlVFmw2d08Ys_uhCzFli7R5vRuiBYP5uX8Ab7DJfkEHPrsz0PcYN8TNGL-G2DvTYvpMPlpoE37ZnVOyuDi_P7vK57eX12en8xwqxftcoALTlEpZVhtBlTClQsuBSmC2AcG4tXUjaImqXiq6FBSZ5IxL0TTSVFU5JT-2vuth2WFj0PcRWr2OroP4rAM4_ffEuwe9Ck-6qutKVHw0-L4ziOHPgKnXnUsG2xY8hiFpJhUrC1aUakS_vc3ah7zucARmW8DEkFJEu0cY1ZuW9K4lvWtpVPB_FMb10Luw-axr_6M73urGgX4MQ_Tjkt-lXwC816g7
CitedBy_id crossref_primary_10_1002_smtd_201700196
crossref_primary_10_2217_nnm_2021_0298
crossref_primary_10_3390_bios13050557
crossref_primary_10_1002_advs_202202051
crossref_primary_10_1186_s12645_017_0031_3
crossref_primary_10_1038_nprot_2017_031
crossref_primary_10_1002_smll_202407787
crossref_primary_10_1002_adfm_201606632
crossref_primary_10_1016_j_jcis_2024_02_113
crossref_primary_10_3390_pharmaceutics13101663
crossref_primary_10_1002_adfm_202309929
crossref_primary_10_1016_j_jmst_2025_03_073
crossref_primary_10_1016_j_apsb_2018_03_007
crossref_primary_10_1016_j_mtchem_2024_101899
crossref_primary_10_1038_s44303_024_00011_9
crossref_primary_10_1070_QEL17475
crossref_primary_10_3389_fbioe_2025_1595772
crossref_primary_10_1002_smll_201801022
crossref_primary_10_1002_wnan_1672
crossref_primary_10_1186_s12951_021_01168_w
crossref_primary_10_1021_acsenvironau_4c00149
crossref_primary_10_1002_ppsc_201800197
crossref_primary_10_1039_C8RA07944G
crossref_primary_10_1080_01932691_2019_1700131
crossref_primary_10_1038_s41467_019_09173_2
crossref_primary_10_1007_s11307_019_01462_y
crossref_primary_10_1080_1061186X_2021_1999963
crossref_primary_10_1007_s40242_021_1130_6
crossref_primary_10_1002_jrs_6637
crossref_primary_10_1007_s11082_019_2141_0
crossref_primary_10_1007_s11307_017_1056_z
crossref_primary_10_1016_j_jcis_2018_11_035
crossref_primary_10_1186_s12951_021_00875_8
crossref_primary_10_1002_adfm_202417341
crossref_primary_10_1016_j_bej_2023_109103
crossref_primary_10_1016_j_ccr_2022_214711
crossref_primary_10_2174_0115734129322567240821052326
crossref_primary_10_1016_j_cplett_2018_03_031
crossref_primary_10_1016_j_trac_2025_118409
crossref_primary_10_1002_cphc_201701228
crossref_primary_10_3390_biomedicines9111554
crossref_primary_10_1002_wnan_70015
crossref_primary_10_1002_adma_202405253
crossref_primary_10_1007_s00259_022_05705_z
crossref_primary_10_2217_nnm_2016_0385
crossref_primary_10_1002_advs_202002788
crossref_primary_10_1016_j_mbs_2018_10_010
crossref_primary_10_1002_smll_202409698
crossref_primary_10_3389_fonc_2022_837234
crossref_primary_10_3390_ma15113893
crossref_primary_10_1002_adfm_201908825
crossref_primary_10_1002_VIW_20220059
crossref_primary_10_1007_s00216_017_0435_2
crossref_primary_10_1002_advs_202405416
crossref_primary_10_1002_wnan_1624
crossref_primary_10_1016_j_ccr_2018_05_007
crossref_primary_10_3390_chemosensors10050150
crossref_primary_10_1002_adfm_202009942
crossref_primary_10_1002_hep_29829
crossref_primary_10_1002_ppsc_201800390
crossref_primary_10_1002_jrs_5575
crossref_primary_10_1039_D1RA08827K
crossref_primary_10_1016_j_cplett_2018_02_045
crossref_primary_10_1021_jacs_8b06347
crossref_primary_10_1002_adbi_201800100
crossref_primary_10_1002_adbi_202200234
crossref_primary_10_1007_s00604_025_07406_4
crossref_primary_10_1063_5_0047578
crossref_primary_10_1021_acsnano_4c10219
crossref_primary_10_26599_NBE_2023_9290024
crossref_primary_10_1038_s41467_022_35696_2
crossref_primary_10_3390_app132312882
crossref_primary_10_1186_s12951_021_00870_z
crossref_primary_10_1016_j_actbio_2020_01_006
crossref_primary_10_1038_s41467_019_11829_y
crossref_primary_10_3390_nano13111733
crossref_primary_10_1002_adom_202302796
crossref_primary_10_1002_jrs_5232
crossref_primary_10_1002_adfm_202003147
crossref_primary_10_3390_ma12010103
crossref_primary_10_1039_D2RA05127C
crossref_primary_10_1073_pnas_2318265121
crossref_primary_10_1088_1361_6528_ad3363
crossref_primary_10_1002_smll_202005236
crossref_primary_10_1002_adma_201904329
crossref_primary_10_1088_1555_6611_ac5804
crossref_primary_10_1002_adma_201707003
crossref_primary_10_1515_ejnm_2017_0005
crossref_primary_10_4329_wjr_v16_i6_139
crossref_primary_10_1038_s41551_022_00891_5
crossref_primary_10_1016_j_cbpa_2018_03_015
crossref_primary_10_1103_PhysRevApplied_17_044029
crossref_primary_10_1016_j_nano_2020_102198
crossref_primary_10_1063_5_0176301
crossref_primary_10_1080_05704928_2025_2465394
crossref_primary_10_1016_j_colsurfa_2018_09_030
crossref_primary_10_1002_INMD_20250037
crossref_primary_10_1038_s41467_018_05113_8
crossref_primary_10_3389_fbioe_2022_1024174
crossref_primary_10_1016_j_saa_2019_117279
Cites_doi 10.1148/radiol.12102394
10.1148/rg.264055120
10.1126/scitranslmed.3010633
10.1148/radiology.183.1.1549696
10.1245/s10434-013-3360-4
10.1016/S0021-9797(03)00422-3
10.2967/jnumed.111.087775
10.1038/sj.onc.1207074
10.1186/1743-8977-4-10
10.1016/j.ejso.2013.12.023
10.1007/s11307-016-0932-2
10.1148/radiol.14141308
10.1073/pnas.1301379110
10.1097/SLA.0b013e31825ffed3
10.1007/s00117-006-1449-5
10.1038/nm.2472
10.1111/jsap.12148
10.1002/anie.201403835
10.2967/jnumed.115.158196
10.1016/j.ejrad.2009.09.002
10.1021/la504511j
10.1016/S0092-8674(00)81079-X
10.7863/ultra.33.1.47
10.1126/scitranslmed.3001963
10.1038/75568
10.1148/radiol.12111703
10.1016/j.ccr.2006.07.012
10.1021/nn503948b
10.2214/ajr.182.5.1821217
10.1016/j.jss.2011.01.009
10.1245/s10434-009-0594-2
10.1002/jmri.1880080511
10.1038/nrclinonc.2011.141
10.11152/mu.201.3.2066.162.cdd1nr2
10.1038/ncomms7570
10.1021/cr300120g
10.1039/a827241z
10.1148/radiol.14131880
10.1101/gad.244368.114
10.1038/nm.2721
10.7150/thno.13842
10.1002/anie.201205748
10.1007/s00464-014-3468-z
ContentType Journal Article
Copyright Copyright © 2016 American Chemical Society
Copyright_xml – notice: Copyright © 2016 American Chemical Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1021/acsnano.5b07200
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1936-086X
EndPage 5026
ExternalDocumentID PMC4884645
27078225
10_1021_acsnano_5b07200
g04387972
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIBIB NIH HHS
  grantid: R01 EB017748
– fundername: NCI NIH HHS
  grantid: P01 CA013106
– fundername: NIDA NIH HHS
  grantid: K08 DA016396
– fundername: NCI NIH HHS
  grantid: P30 CA008748
– fundername: NCI NIH HHS
  grantid: U01 CA168409
– fundername: NCI NIH HHS
  grantid: K08 CA163961
GroupedDBID -
23M
53G
55A
5GY
7~N
AABXI
ABMVS
ABUCX
ACGFS
ACS
AEESW
AENEX
AFEFF
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
CS3
EBS
ED
ED~
EJD
F5P
GNL
IH9
IHE
JG
JG~
P2P
RNS
ROL
UI2
VF5
VG9
W1F
XKZ
YZZ
---
.K2
4.4
5VS
6J9
AAHBH
AAYXX
ABBLG
ABJNI
ABLBI
ABQRX
ACBEA
ACGFO
ADHGD
ADHLV
AHGAQ
BAANH
CITATION
CUPRZ
GGK
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-a495t-6e9acd399f18c6096c39ef5a07a1fda615ff8d603e98b90b60e1751576dd7c443
IEDL.DBID ACS
ISICitedReferencesCount 145
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000376825100014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1936-0851
1936-086X
IngestDate Tue Sep 30 16:48:52 EDT 2025
Fri Jul 11 07:42:47 EDT 2025
Mon Jul 21 05:51:52 EDT 2025
Tue Nov 18 22:17:43 EST 2025
Sat Nov 29 02:49:56 EST 2025
Thu Aug 27 13:42:36 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords nanoparticles
sarcoma
intraoperative imaging
surface-enhanced Raman scattering
image-guided tumor resection
hepatocellular carcinoma
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a495t-6e9acd399f18c6096c39ef5a07a1fda615ff8d603e98b90b60e1751576dd7c443
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://doi.org/10.1021/acsnano.5b07200
PMID 27078225
PQID 1791321239
PQPubID 23479
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4884645
proquest_miscellaneous_1791321239
pubmed_primary_27078225
crossref_primary_10_1021_acsnano_5b07200
crossref_citationtrail_10_1021_acsnano_5b07200
acs_journals_10_1021_acsnano_5b07200
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
XKZ
7~N
VG9
W1F
ACS
AEESW
AFEFF
ABMVS
ABUCX
IH9
AQSVZ
ED~
UI2
PublicationCentury 2000
PublicationDate 2016-05-24
PublicationDateYYYYMMDD 2016-05-24
PublicationDate_xml – month: 05
  year: 2016
  text: 2016-05-24
  day: 24
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle ACS nano
PublicationTitleAlternate ACS Nano
PublicationYear 2016
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref9/cit9
ref6/cit6
ref36/cit36
ref3/cit3
ref27/cit27
ref18/cit18
ref11/cit11
ref25/cit25
ref16/cit16
ref29/cit29
Huang R. (ref17/cit17) 2016; 6
ref32/cit32
ref23/cit23
ref39/cit39
ref14/cit14
ref8/cit8
ref5/cit5
ref31/cit31
ref2/cit2
ref43/cit43
ref34/cit34
ref37/cit37
ref28/cit28
ref40/cit40
ref20/cit20
ref10/cit10
ref26/cit26
ref35/cit35
ref19/cit19
ref21/cit21
ref12/cit12
ref15/cit15
ref42/cit42
ref41/cit41
ref22/cit22
ref13/cit13
ref33/cit33
ref4/cit4
ref30/cit30
ref1/cit1
ref24/cit24
ref38/cit38
ref7/cit7
References_xml – ident: ref6/cit6
  doi: 10.1148/radiol.12102394
– ident: ref8/cit8
  doi: 10.1148/rg.264055120
– ident: ref19/cit19
  doi: 10.1126/scitranslmed.3010633
– ident: ref25/cit25
  doi: 10.1148/radiology.183.1.1549696
– ident: ref11/cit11
  doi: 10.1245/s10434-013-3360-4
– ident: ref41/cit41
  doi: 10.1016/S0021-9797(03)00422-3
– ident: ref12/cit12
  doi: 10.2967/jnumed.111.087775
– ident: ref33/cit33
  doi: 10.1038/sj.onc.1207074
– ident: ref27/cit27
  doi: 10.1186/1743-8977-4-10
– ident: ref3/cit3
  doi: 10.1016/j.ejso.2013.12.023
– ident: ref16/cit16
  doi: 10.1007/s11307-016-0932-2
– ident: ref34/cit34
  doi: 10.1148/radiol.14141308
– ident: ref39/cit39
  doi: 10.1073/pnas.1301379110
– ident: ref1/cit1
  doi: 10.1097/SLA.0b013e31825ffed3
– ident: ref4/cit4
  doi: 10.1007/s00117-006-1449-5
– ident: ref38/cit38
  doi: 10.1038/nm.2472
– ident: ref10/cit10
  doi: 10.1111/jsap.12148
– ident: ref13/cit13
  doi: 10.1002/anie.201403835
– ident: ref18/cit18
  doi: 10.2967/jnumed.115.158196
– ident: ref28/cit28
  doi: 10.1016/j.ejrad.2009.09.002
– ident: ref26/cit26
  doi: 10.1021/la504511j
– ident: ref32/cit32
  doi: 10.1016/S0092-8674(00)81079-X
– ident: ref9/cit9
  doi: 10.7863/ultra.33.1.47
– ident: ref36/cit36
  doi: 10.1126/scitranslmed.3001963
– ident: ref42/cit42
  doi: 10.1038/75568
– ident: ref24/cit24
  doi: 10.1148/radiol.12111703
– ident: ref31/cit31
  doi: 10.1016/j.ccr.2006.07.012
– ident: ref14/cit14
  doi: 10.1021/nn503948b
– ident: ref29/cit29
  doi: 10.2214/ajr.182.5.1821217
– ident: ref37/cit37
  doi: 10.1016/j.jss.2011.01.009
– ident: ref40/cit40
  doi: 10.1245/s10434-009-0594-2
– ident: ref30/cit30
  doi: 10.1002/jmri.1880080511
– ident: ref5/cit5
  doi: 10.1038/nrclinonc.2011.141
– ident: ref7/cit7
  doi: 10.11152/mu.201.3.2066.162.cdd1nr2
– ident: ref20/cit20
  doi: 10.1038/ncomms7570
– ident: ref22/cit22
  doi: 10.1021/cr300120g
– ident: ref23/cit23
  doi: 10.1039/a827241z
– ident: ref35/cit35
  doi: 10.1148/radiol.14131880
– ident: ref43/cit43
  doi: 10.1101/gad.244368.114
– ident: ref15/cit15
  doi: 10.1038/nm.2721
– volume: 6
  start-page: 1075
  year: 2016
  ident: ref17/cit17
  publication-title: Theranostics
  doi: 10.7150/thno.13842
– ident: ref21/cit21
  doi: 10.1002/anie.201205748
– ident: ref2/cit2
  doi: 10.1007/s00464-014-3468-z
SSID ssj0057876
Score 2.5536556
Snippet Complete surgical resection is the ideal first-line treatment for most liver malignancies. This goal would be facilitated by an intraoperative imaging method...
Complete surgical resection is the first-line treatment for most liver malignancies. This goal would be facilitated by an intraoperative imaging method that...
SourceID pubmedcentral
proquest
pubmed
crossref
acs
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 5015
SubjectTerms Animals
Carcinoma, Hepatocellular - diagnostic imaging
Liver Neoplasms - diagnostic imaging
Nanoparticles
Silicon Dioxide
Spectrum Analysis, Raman
Title Imaging of Liver Tumors Using Surface-Enhanced Raman Scattering Nanoparticles
URI http://dx.doi.org/10.1021/acsnano.5b07200
https://www.ncbi.nlm.nih.gov/pubmed/27078225
https://www.proquest.com/docview/1791321239
https://pubmed.ncbi.nlm.nih.gov/PMC4884645
Volume 10
WOSCitedRecordID wos000376825100014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVABC
  databaseName: American Chemical Society Journals
  customDbUrl:
  eissn: 1936-086X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0057876
  issn: 1936-0851
  databaseCode: ACS
  dateStart: 20070801
  isFulltext: true
  titleUrlDefault: https://pubs.acs.org/action/showPublications?display=journals
  providerName: American Chemical Society
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEB58HfTg-1FfrODBSzRJk2z2KKWioCJWobcw2exSwW6kaf39zm7TahVBz9ldNvPY-YYZvgE4jVJF_iesp2nhRbqQnkCeeyiFlEWciAhzN2yC39-n3a54-CSL_l7BD4MLlJVBU57Huc9JpfOwGBLItcZ82epMHl1rd8m4gEwJMqGIKYvPjwNsGJLVbBj6gS2_t0h-iTlXa_-47Tqs1sCSXY4tYQPmlNmElS90g1twd9N3M4lYqdmt7cdgT6N-OaiY6xtgndFAo1Re2_RcWwB7xD4a1pGOgtOuoKeYcuy6lW4bnq_aT61rrx6n4CFlQUMvUQJlQYBEB6lMKHWRTaF0jD7HQBdI0EbrtEj8phJpLvw88RVhi4ASkqLgMoqaO7BgSqP2gKmmFtrnKidxU8YTiVDHoUJEX2MieNGAUxJEVrtDlblKdxhktXSyWjoNOJ8oIZM1JbmdjPH6-4az6Ya3MRvH70tPJlrNyGNsGQSNKkd0GS4oBaeILRqwO9by9LDQEQiGcQP4jP6nCywb9-wX89JzrNz0Etoq8f7ffv0Algl6JbYPIYwOYWE4GKkjWJLvw5dqcAzzvJseOwv_AFxE-LI
linkProvider American Chemical Society
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dT9swED-xMmnbAzDGtsAGnsTDXgJJmsTxI0KgVisVWovEW3RxbFGJOlPT7u_f2U0KBSGx18Q-Offhu9NdfgdwHGeK7E9YS9PCj3UpfYG88FEKKcskFTEWbtgEHw6z21txvQFB-y8MHaImSrUr4j-gC4Sn9MygqU6SIuAk2TewmZBztZp9dj5q716rfumyjkx5MgUTKzCfZwSsN5L1ujd6FmI-7ZR85Hout___0Duw1YSZ7GypFx9hQ5ld-PAIfPATXPWnbkIRqzQb2O4MNl5Mq1nNXBcBGy1mGqXyL8ydaxJgv3GKho2kA-S0K-hipoy7aazbg5vLi_F5z2-GK_hIOdHcT5VAWVJ4osNMppTIyK5QOsGAY6hLpEBH66xMg64SWSGCIg0URRohpSdlyWUcdz9Dx1RGfQWmulrogKuCuE75TywinUQKEQONqeClB8fEiLwxjjp3de8ozBvu5A13PDhpZZHLBqDczsm4f3nDz9WGP0tsjpeX_miFm5P92KIIGlUt6DBcUEJO_lt48GUp7BWxyMEJRokHfE0NVgssNvf6GzO5cxjddC_amvH-6z79CN71xleDfNAf_jqA9xSUpbZDIYq_QWc-W6jv8Fb-nU_q2aFT93-QMgA_
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB61FFVw6AsK6XMrcejFwXZsr_cYAVFRaYQIlbhZ430IpGaN4oTfz-xmEyVFSIir96H1PHZmNLPfABxkpSb9E07TjIgyo2QkkNcRSiGlyguRYe2bTfDhsLy6EufhUZh7C0OHaGmn1ifxnVbfKhMQBpJD-m7RNt28jjlx9yW8ysmcO-nuH40W968TwWKeS6ZYmRyKJaDPgw2cRZLtukV64Gb-Xy25Yn4Gb5938HfwJribrD-Xj_fwQtsPsL0CQrgDf07HvlMRaww7c1Ua7HI2biYt89UEbDSbGJQ6OrHXvliAXeAYLRtJD8zpZtAFTZF3KLDbhb-Dk8ujX1FoshAhxUbTqNACpSI3xSSlLCigkT2hTY4xx8QoJIfHmFIVcU-LshZxXcSaPI6EwhSluCTqf4QN21i9D0z3jDAx1zVRnuKgTKQmTzUixgYLwVUHDogQVVCStvL57zSpAnWqQJ0OdBf8qGQAKnf9Mv49vuDncsHtHKPj8ak_FgyuSI9ccgStbmZ0GC4oMCc7LjqwN2f4crPUwwqmeQf4migsJziM7vURe3PtsbrpfnS5409P-_Xv8Pr8eFCdnQ5_f4Yt8s0KV6iQZl9gYzqZ6a-wKe-mN-3km5f4e7ctArk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Imaging+of+Liver+Tumors+Using+Surface-Enhanced+Raman+Scattering+Nanoparticles&rft.jtitle=ACS+nano&rft.au=Andreou%2C+Chrysafis&rft.au=Neuschmelting%2C+Volker&rft.au=Tschaharganeh%2C+Darjus-Felix&rft.au=Huang%2C+Chun-Hao&rft.date=2016-05-24&rft.issn=1936-0851&rft.eissn=1936-086X&rft.volume=10&rft.issue=5&rft.spage=5015&rft.epage=5026&rft_id=info:doi/10.1021%2Facsnano.5b07200&rft_id=info%3Apmid%2F27078225&rft.externalDocID=PMC4884645
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1936-0851&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1936-0851&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1936-0851&client=summon